Literature DB >> 8995100

Cancer of the oldest old. What we have learned from autopsy studies.

G Stanta1, L Campagner, F Cavallieri, L Giarelli.   

Abstract

Cancer in the oldest old is a novel problem, due to the recent burgeoning of the population aged 85 and older. This article addresses three critical questions related to cancer in the oldest old: Does the incidence of cancer increase after age 95? Is cancer a common cause of death for the oldest old? Is cancer accurately diagnosed in the oldest old? The authors analyzed a group of 507 autopsies of elderly, divided in three age groups, 75 90 years, 95 99, and over 99 (centenarians). The prevalence of cancer was 35% among the younger persons and 20% and 16% respectively for those aged 95 99 and for the centenarians. A fourth of the patients in the younger group died from cancer but only 9.5% of the people between 95 and 98 years and 7.1% of the centenarians died from cancer. The cancer was the direct cause of death for 67% of the younger persons and 41% of patients belonging to the two oldest groups. The prevalence of metastases was 63% for tumors occurring in persons aged 75 90, 32% in persons aged 95 98, and 29% in the centenarians. Cancer had been accurately diagnosed prior to death in 67.4% of persons aged 75 90, in 38.5% of those aged 95 99, and 29.4% of the centenarian. Cancer as cause of death had been underestimated in 16% of the cases in the younger persons and in almost 50% of cases of the oldest old. This study suggests that the incidence of cancer and the importance of cancer as a cause of death may decline after age 95 and that the clinical diagnoses underestimate significantly both the incidence of cancer and the prevalence of cancer deaths in the oldest old.

Entities:  

Mesh:

Year:  1997        PMID: 8995100

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  17 in total

1.  An age-period-cohort analysis of cancer incidence among the oldest old, Utah 1973-2002.

Authors:  Heidi A Hanson; Ken R Smith; Antoinette M Stroup; C Janna Harrell
Journal:  Popul Stud (Camb)       Date:  2014-11-14

2.  Age patterns of incidence of geriatric disease in the U.S. elderly population: Medicare-based analysis.

Authors:  Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Anatoliy I Yashin
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

Review 3.  Subdividing the age group of 85 years and older to improve US disease reporting.

Authors:  Francis P Boscoe
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

Review 4.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

5.  Age-specific cancer mortality trends in 16 countries.

Authors:  Lee Liu; Kristen Liu
Journal:  Int J Public Health       Date:  2016-07-14       Impact factor: 3.380

Review 6.  Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.

Authors:  Cristina Lanni; Mirco Masi; Marco Racchi; Stefano Govoni
Journal:  Mol Psychiatry       Date:  2020-05-07       Impact factor: 15.992

7.  Is cancer incidence decreased in the frail elderly? Evidence from a prospective cohort study.

Authors:  Bindu Kanapuru; Eleanor M Simonsick; William B Ershler
Journal:  J Geriatr Oncol       Date:  2012-09-14       Impact factor: 3.599

Review 8.  How ageing processes influence cancer.

Authors:  João Pedro de Magalhães
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

Review 9.  Common cancers in the elderly.

Authors:  J Hansen
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

10.  Clinical analysis of multiple primary malignancies in the elderly.

Authors:  Andrea Luciani; G Ascione; D Marussi; S Oldani; S Caldiera; S Bozzoni; C Codecà; S Zonato; D Ferrari; P Foa
Journal:  Med Oncol       Date:  2008-05-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.